Craig E. Fraser's Insider Trades & SAST Disclosures
Craig E. Fraser's most recent trade in Windtree Therapeutics Inc was a trade of 5,431 Common Stock done at an average price of $0.9 . Disclosure was reported to the exchange on Oct. 8, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Craig E. Fraser.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Windtree Therapeutics Inc | Craig E. Fraser | Director, President and CEO | 08 Oct 2024 | 5,431 | 8,638 (0%) | 0% | 0.9 | 4,942 | Common Stock | |
| Windtree Therapeutics Inc | Craig E. Fraser | Director, President and CEO | 22 Jul 2024 | 4,011 | 4,011 | - | - | Warrants (Right to Buy) | ||
| Windtree Therapeutics Inc | Craig E. Fraser | Director, President and CEO | 22 Jul 2024 | 19 | 19 | - | - | Series C Preferred Stock | ||
| Windtree Therapeutics Inc | Craig E. Fraser | Director, President and CEO | 23 Aug 2023 | 68,800 | 68,800 | - | - | Employee Stock Option (Right to Buy) | ||
| Windtree Therapeutics Inc | Craig E. Fraser | Director, President and CEO | 23 Aug 2023 | 45,867 | 52,877 (0%) | 0% | 0 | Common Stock | ||
| Windtree Therapeutics Inc | Craig E. Fraser | Director, President and CEO | 26 Apr 2023 | 1,497 | 7,010 (0%) | 0% | 1.8 | 2,650 | Common Stock | |
| Windtree Therapeutics Inc | Craig E. Fraser | Director, President and CEO | 25 Apr 2023 | 1,315 | 5,513 (0%) | 0% | 1.9 | 2,485 | Common Stock | |
| Windtree Therapeutics Inc | Craig E. Fraser | Director, President and CEO | 28 Feb 2023 | 334 | 4,198 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges